Mutations of ferric uptake regulator (fur) impair iron homeostasis, growth, oxidative stress survival, and virulence of Xanthomonas campestris pv. campestris. Jittawuttipoka T, Sallabhan R, Vattanaviboon P, Fuangthong M, Mongkolsuk S Arch Microbiol192p331-9(2010 May)

28 Dec 2010
0
0

Mutations of ferric uptake regulator (fur) impair iron homeostasis, growth, oxidative stress survival, and virulence of Xanthomonas campestris pv. campestris.
Jittawuttipoka T, Sallabhan R, Vattanaviboon P, Fuangthong M, Mongkolsuk S
Arch Microbiol192p331-9(2010 May)

Tags

Share this

Related Posts

Wongkanya, R.; Asamo, S.; Dechtrirat, D.; Sudchanham, J.; Srisamran, N.; Sriprachuabwong, C.; Tuantranont, A.; Chattham, N.; Hannongbua, S.; Prajongtat, P. Enhancing the Stability and Performance of Two-Dimensional Perovskite Solar Cells via Double-Step Homogeneous Precursor Mixing. ACS Appl. Energy Mater. 2022, 5, 12415–12426.
27 Sep 2022
0

Wongkanya, R.; Asamo, S.; Dechtrirat, D.; Sudchanham, J.; Srisamran, N.; Sriprachuabwong, C.; Tuantranont, A.; Chattham, N.; Hannongbua, S.; Prajongtat, P. Enhancing the Stability and Performance of Two-Dimensional Perovskite Solar Cells via Double-Step Homogeneous Precursor Mixing. ACS Appl. Energy Mater. 2022, 5, 12415–12426.

Wongkanya, R.; Asamo, S.; Dechtrirat, D.; Sudchanham, J.; Srisamran, N.; Sriprachuabwong, C.; Tuantranont, A.; Chattham, N.; Hannongbua, S.; Prajongtat, P. Enhancing the Stability and Performance of Two-Dimensional Perovskite Solar Cells via Double-Step Homogeneous Precursor Mixing. ACS Appl. Energy Mater. 2022, 5, 12415–12426.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More